These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 4051511
1. [Phase II study of 4'-O-tetrahydropyranyl-adriamycin (THP-ADM) in patients with gynecological cancer]. Kato T, Nishimura H, Umezu J, Takeuchi S, Kanazawa K, Inoue H, Suzuki M, Hirono M, Suzuki T, Okajima H. Gan To Kagaku Ryoho; 1985 Oct; 12(10):1962-7. PubMed ID: 4051511 [Abstract] [Full Text] [Related]
2. [Preliminary phase II clinical study of 4'-O-tetrahydropyranyl doxorubicin (THP-ADM)]. Majima H. Gan To Kagaku Ryoho; 1983 Mar; 10(3):805-10. PubMed ID: 6882000 [Abstract] [Full Text] [Related]
3. [Phase II study of (2''R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with solid tumors. Multi-Institutional Cooperative Study]. Saito T, Kasai Y, Wakui A, Furue H, Majima H, Nitani H, Niijima T, Takeda C, Abe O, Koyama Y. Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1060-9. PubMed ID: 3963850 [Abstract] [Full Text] [Related]
6. [Cardiotoxicity due to prolonged administration of THP (2"R-4'-O-tetrahydropyranyl-adriamycin)]. Suzuki M, Hirono M, Majima H. Gan To Kagaku Ryoho; 1997 Oct; 24(13):1993-9. PubMed ID: 9350248 [Abstract] [Full Text] [Related]
9. [Paclitaxel and carboplatin with or without pirarubicin (THP-ADR) as first line chemotherapy in elderly patients]. Nagao S, Okimoto N, Hongo A, Mizutani Y, Kodama J, Yoshinouchi M, Hiramatsu Y, Kudo T. Gan To Kagaku Ryoho; 2003 Feb; 30(2):243-9. PubMed ID: 12610873 [Abstract] [Full Text] [Related]
11. [Phase II study of (2''R)-4'-O-tetrahydropyranyldoxorubicin (THP) in patients with advanced gastrointestinal cancer--a report of the Tohoku THP Study Group]. Wakui A, Yokoyama M, Yoshida Y, Kikuchi Y, Osawa I, Masamune O, Matsuoka T, Sato S, Kikuchi K, Shoji T. Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1032-7. PubMed ID: 3963848 [Abstract] [Full Text] [Related]
13. Combination therapy with pegylated liposomal doxorubicin and carboplatin in gynecologic malignancies: a prospective phase II study of the Arbeitsgemeinschaft Gynäekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and Kommission Uterus (AGO-K-Ut). du Bois A, Pfisterer J, Burchardi N, Loibl S, Huober J, Wimberger P, Burges A, Stähle A, Jackisch C, Kölbl H, Arbeitsgemeinschaft Gynäekologische Onkologie Studiengruppe Ovarialkarzinom, Kommission Uterus. Gynecol Oncol; 2007 Dec; 107(3):518-25. PubMed ID: 17910981 [Abstract] [Full Text] [Related]
15. [A phase II study of (2''R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with head and neck cancer]. Takeda C. Gan To Kagaku Ryoho; 1986 May; 13(5):1970-9. PubMed ID: 3707155 [Abstract] [Full Text] [Related]
17. [Ozone-oxygen injection in gynecological radiotherapy]. Hernuss P, Müller-Tyl E, Dimopoulos J. Strahlentherapie; 1974 Sep; 148(3):242-5. PubMed ID: 4446040 [No Abstract] [Full Text] [Related]
18. [Analysis of side effects of a combination chemotherapy of cisplatin and adriamycin in gynecological malignancies: comparison between intravenous and intraarterial administration]. Kawagoe K, Tsunoda H, Iijima S, Yokota H, Shigemitsu S. Gan To Kagaku Ryoho; 1984 Mar; 11(3):452-7. PubMed ID: 6538404 [Abstract] [Full Text] [Related]
19. Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent carcinoma of the uterine cervix and vagina. Long HJ, Cross WG, Wieand HS, Webb MJ, Mailliard JA, Kugler JW, Tschetter LK, Kardinal CG, Ebbert LP, Rayson S. Gynecol Oncol; 1995 May; 57(2):235-9. PubMed ID: 7729741 [Abstract] [Full Text] [Related]
20. [Phase II collaborative study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) for urological malignancies--Urological Co-operative THP Study Group]. Niijima T, Koyanagi T, Sakashita S, Origasa S, Akaza H, Machida T, Koiso K, Rinsho K, Aso Y, Suzuki K. Gan To Kagaku Ryoho; 1986 Feb; 13(2):224-31. PubMed ID: 3947104 [Abstract] [Full Text] [Related] Page: [Next] [New Search]